Επίσημη σελίδα
The anti-spike-protein IgG3 response appeared best for distinguishing infected from uninfected individuals, while agreeing most closely with a standard viral neutralization test. Several serologic assays are available for detecting … Read More
A single dose of Johnson & Johnson’s Ad26.COV2.S vaccine appears to be safe and induce an immune response in two age groups, according to interim results of a phase … Read More
First, a study examined the time from quarantine to positive SARS-CoV-2 test in college athletes. More of the 1800 quarantined athletes had exposures from social gatherings (41%) or roommates … Read More
The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease. Moreover, thromboembolic events throughout the body, including in the CNS, have been described. … Read More
Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness. Although COVID-19 is primarily a respiratory disease, patients often experience neurological … Read More
Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients. Among critically … Read More
Most patients with asymptomatic or mild COVID-19 have detectable SARS-CoV-2 antibodies 8 months after infection, researchers report in Emerging Infectious Diseases. Some 58 patients in South Korea underwent antibody testing … Read More
A neutralizing monoclonal antibody that’s authorized to treat COVID-19 outpatients did not improve outcomes in hospitalized patients, according to findings in the New England Journal of Medicine. Some 300 … Read More
COVID-19 mortality rates declined over the first 6 months of the pandemic, according to a JAMA Internal Medicine study. Using data from a large U.S. health insurer, researchers studied some 28,000 … Read More
Novavax’s investigational vaccine, NVX-CoV2373, is made from a stabilized form of the coronavirus spike protein using the company’s recombinant protein nanoparticle technology. The purified protein antigens in the … Read More
